Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

Imagem de Miniatura
Arquivos
art_FOTOPOULOU_Outcomes_of_gynecologic_cancer_surgery_during_the_COVID19_2022.PDF (1.15 MB)
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MOSBY-ELSEVIER
Autores
FOTOPOULOU, Christina
KHAN, Tabassum
BRACINIK, Juraj
GLASBEY, James
ABU-RUSTUM, Nadeem
CHIVA, Luis
FAGOTTI, Anna
FUJIWARA, Keiichi
GHEBRE, Rahel
GUTELKIN, Murat
Citação
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, v.227, n.5, article ID 735, 25p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: The CovidSurg-Cancer Consortium aimed to explore the impact of COVID-19 in surgical patients and services for solid cancers at the start of the pandemic. The CovidSurg-Gynecologic Oncology Cancer subgroup was particularly concerned about the magnitude of adverse outcomes caused by the disrupted surgical gynecologic cancer care during the COVID-19 pandemic, which are currently unclear. OBJECTIVE: This study aimed to evaluate the changes in care and short-term outcomes of surgical patients with gynecologic cancers during the COVID-19 pandemic. We hypothesized that the COVID-19 pandemic had led to a delay in surgical cancer care, especially in patients who required more extensive surgery, and such delay had an impact on cancer outcomes. STUDY DESIGN: This was a multicenter, international, prospective cohort study. Consecutive patients with gynecologic cancers who were initially planned for nonpalliative surgery, were recruited from the date of first COVID-19-related admission in each participating center for 3 months. The follow-up period was 3 months from the time of the multidisciplinary tumor board decision to operate. The primary outcome of this analysis is the incidence of pandemic-related changes in care. The secondary outcomes included 30-day perioperative mortality and morbidity and a composite outcome of unresectable disease or disease progression, emergency surgery, and death. RESULTS: We included 3973 patients (3784 operated and 189 nonoperated) from 227 centers in 52 countries and 7 world regions who were initially planned to have cancer surgery. In 20.7% (823/3973) of the patients, the standard of care was adjusted. A significant delay (>8 weeks) was observed in 11.2% (424/3784) of patients, particularly in those with ovarian cancer (213/1355; 15.7%; P<.0001). This delay was associated with a composite of adverse outcomes, including disease progression and death (95/424; 22.4% vs 601/3360; 17.9%; P<1/4>.024) compared with those who had operations within 8 weeks of tumor board decisions. One in 13 (189/2430; 7.9%) did not receive their planned operations, in whom 1 in 20 (5/189; 2.7%) died and 1 in 5 (34/189; 18%) experienced disease progression or death within 3 months of multidisciplinary team board decision for surgery. Only 22 of the 3778 surgical patients (0.6%) acquired perioperative SARS-CoV-2 infections; they had a longer postoperative stay (median 8.5 vs 4 days; P<.0001), higher predefined surgical morbidity (14/22; 63.6% vs 717/3762; 19.1%; P<.0001) and mortality (4/22; 18.2% vs 26/3762; 0.7%; P<.0001) rates than the uninfected cohort. CONCLUSION: One in 5 surgical patients with gynecologic cancer worldwide experienced management modifications during the COVID-19 pandemic. Significant adverse outcomes were observed in those with delayed or cancelled operations, and coordinated mitigating strategies are urgently needed.
Palavras-chave
complications, COVID-19, delay, gynecologic cancer, pandemic, surgery
URI
https://observatorio.fm.usp.br/handle/OPI/53905
Referências
  1. Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241102
  2. Altin D, 2020, J TURK-GER GYNECOL A, V21, P265, DOI 10.4274/jtgga.galenos.2020.2020.0071
  3. American Society of Clinical Oncology, 2022, COVID 19 PAT CAR INF
  4. Bhangu A, 2021, COLORECTAL DIS, V23, P732, DOI 10.1111/codi.15431
  5. Bruce SF, 2022, GYNECOL ONCOL REP, V39, DOI 10.1016/j.gore.2022.100928
  6. Burnell M, 2016, BJOG-INT J OBSTET GY, V123, P2171, DOI 10.1111/1471-0528.13994
  7. Chen ZL, 2021, J OVARIAN RES, V14, DOI 10.1186/s13048-021-00784-2
  8. Fader AN, 2020, GYNECOL ONCOL, V158, P236, DOI 10.1016/j.ygyno.2020.06.001
  9. Frey MK, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.06.049
  10. Glasbey JC, 2021, LANCET ONCOL, V22, P1507, DOI 10.1016/S1470-2045(21)00493-9
  11. Glasbey JC, 2021, J CLIN ONCOL, V39, P66, DOI 10.1200/JCO.20.01933
  12. Gultekin M, 2021, CANCER MED-US, V10, P208, DOI 10.1002/cam4.3605
  13. Hanna TP, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4087
  14. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  15. Jacome LS, 2021, CANCER MANAG RES, V13, P359, DOI 10.2147/CMAR.S287152
  16. Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6
  17. Leung E, 2021, GYNECOL ONCOL, V160, P649, DOI 10.1016/j.ygyno.2020.12.013
  18. Levitt EB, 2022, JAAOS GLOB RES REV, V6, DOI 10.5435/JAAOSGlobal-D-21-00282
  19. National Confidential Enquiry into Patient Outcome and Death, NCEPOD CLASS INT 200
  20. Ramirez PT, 2020, INT J GYNECOL CANCER, V30, P561, DOI 10.1136/ijgc-2020-001419
  21. Royal College of Obstetricians and Gynaecologists
  22. British Gynaecological Cancer Society, 2021, JOINT RCOG BGCS GUID
  23. Sammour T, 2017, TECH COLOPROCTOL, V21, P35, DOI 10.1007/s10151-016-1567-7
  24. The National Institute for Health and Care Excellence, 2020, SPEC GUID PAT MAN CO
  25. Vecchione L, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000826
  26. Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806
  27. Wang YM, 2020, J GYNECOL ONCOL, V31, DOI 10.3802/jgo.2020.31.e68

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Carregar mais